Transurethral collagen injection for treatment of postprostatectomy urinary incontinence in men

Urology. 1997 Jun;49(6):907-12. doi: 10.1016/s0090-4295(97)00093-9.

Abstract

Objectives: Transurethral injection of glutaraldehyde cross-linked bovine collagen has recently been advocated as a potentially useful treatment modality for management of urinary incontinence. The reported clinical experience with urethral collagen injection in adult males has been limited.

Methods: This study summarizes the current literature and reviews the clinical results of collagen injection in a group of 25 men with incontinence after either transurethral or radical prostatectomy.

Results: The overall results in this series were disappointing. Only 2 patients (8%) achieved significant improvement with this treatment. Eight patients (32%) experienced minimal improvement in symptoms, and 15 (60%) remained incontinent with no improvement in symptoms after collagen injection. The number of injection procedures and volume of collagen material implanted did not correlate with clinical outcome. Five patients (20%) have subsequently required placement of an artificial urinary sphincter to control their incontinence.

Conclusions: We conclude that transurethral injection of glutaraldehyde cross-linked bovine collagen has a limited role in the management of urinary incontinence in adult men after prostatectomy.

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Aged
  • Biocompatible Materials / administration & dosage*
  • Collagen / administration & dosage*
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Prostatectomy / adverse effects*
  • Urinary Incontinence / etiology
  • Urinary Incontinence / therapy*

Substances

  • Biocompatible Materials
  • glutaraldehyde-cross-linked collagen
  • Collagen